Elicio Therapeutics (ELTX) Treasury Shares (2020 - 2026)
Elicio Therapeutics posted quarterly Treasury Shares of $150000.0 for Q1 2026, little changed year-on-year from $150000.0 in Q1 2025, and little changed on a QoQ basis from $150000.0 in Q4 2025.
Elicio Therapeutics (ELTX) has 6 years of Treasury Shares data on file, last reported at $150000.0 in Q1 2026.
- For the quarter ending Q1 2026, Treasury Shares changed 0.0% year-over-year to $150000.0; the trailing twelve-month figure through Mar 2026 stood at $150000.0 (changed 0.0% YoY), and the FY2025 full-year result was $150000.0, changed 0.0% from the prior year.
- Treasury Shares for Q1 2026 stood at $150000.0, roughly flat from $150000.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $235234.0 in Q1 2026 and bottomed at $14455.0 in Q2 2023.
- The 4-year median for Treasury Shares is $14455.0 (2023), against an average of $32853.2.
- Peak annual rise in Treasury Shares reached 0.0% in 2024, while the deepest fall reached 0.0% in 2024.
- A 4-year view of Treasury Shares shows it stood at $150000.0 in 2023, then changed by 0.0% to $150000.0 in 2024, then changed by 0.0% to $150000.0 in 2025, then changed by 0.0% to $150000.0 in 2026.
- The last three Treasury Shares figures came in at $150000.0 (Q1 2026), $150000.0 (Q4 2025), and $150000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 265,401.92 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 700,000.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 34.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Elicio Therapeutics | 217.63 Mn | 202.68 Mn | - | 235,234.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 150,000.00 |
| Mar 31, 2026 | 235,234.00 |
| Mar 31, 2026 | 150,000.00 |
| Mar 31, 2026 | 235,234.00 |
| Dec 31, 2025 | 14,455.00 |
| Dec 31, 2025 | 150,000.00 |
| Dec 31, 2025 | 150,000.00 |
| Dec 31, 2025 | 14,455.00 |
| Sep 30, 2025 | 150,000.00 |
| Sep 30, 2025 | 14,455.00 |
| Sep 30, 2025 | 14,455.00 |
| Sep 30, 2025 | 150,000.00 |
| Jun 30, 2025 | 150,000.00 |
| Jun 30, 2025 | 150,000.00 |
| Jun 30, 2025 | 14,455.00 |
| Jun 30, 2025 | 14,455.00 |
| Mar 31, 2025 | 14,455.00 |
| Mar 31, 2025 | 14,455.00 |
| Mar 31, 2025 | 150,000.00 |
| Mar 31, 2025 | 150,000.00 |
| Dec 31, 2024 | 150,000.00 |
| Dec 31, 2024 | 14,455.00 |
| Dec 31, 2024 | 150,000.00 |
| Dec 31, 2024 | 14,455.00 |
| Sep 30, 2024 | 14,455.00 |
| Sep 30, 2024 | 150,000.00 |
| Sep 30, 2024 | 14,455.00 |
| Sep 30, 2024 | 150,000.00 |
| Jun 30, 2024 | 14,455.00 |
| Jun 30, 2024 | 14,455.00 |
| Jun 30, 2024 | 150,000.00 |
| Jun 30, 2024 | 150,000.00 |
| Mar 31, 2024 | 150,000.00 |
| Mar 31, 2024 | 150,000.00 |
| Mar 31, 2024 | 14,455.00 |
| Mar 31, 2024 | 14,455.00 |
| Dec 31, 2023 | 14,455.00 |
| Dec 31, 2023 | 14,455.00 |
| Dec 31, 2023 | 150,000.00 |
| Dec 31, 2023 | 150,000.00 |
| Sep 30, 2023 | 150,000.00 |
| Sep 30, 2023 | 150,000.00 |
| Sep 30, 2023 | 14,455.00 |
| Sep 30, 2023 | 14,455.00 |
| Jun 30, 2023 | 14,455.00 |
| Jun 30, 2023 | 14,455.00 |
| Jun 30, 2023 | 150,000.00 |
| Jun 30, 2023 | 150,000.00 |
| Sep 30, 2021 | 480,943.00 |
| Sep 30, 2021 | 480,943.00 |
| Sep 30, 2021 | 4.21 Mn |
| Sep 30, 2021 | 4.21 Mn |
| Jun 30, 2021 | 480,943.00 |
| Jun 30, 2021 | 480,943.00 |
| Jun 30, 2021 | 4.20 Mn |
| Jun 30, 2021 | 4.20 Mn |
| Mar 31, 2021 | 2.99 Mn |
| Mar 31, 2021 | 2.99 Mn |
| Mar 31, 2021 | 393,148.00 |
| Mar 31, 2021 | 393,148.00 |
| Dec 31, 2020 | 1.85 Mn |
| Dec 31, 2020 | 1.85 Mn |
| Dec 31, 2020 | 316,088.00 |
| Dec 31, 2020 | 316,088.00 |